Rankings
▼
Calendar
CGEM Q1 2019 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$841M
Q1 2019 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-5.94
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$8,500
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$33M
Cash & Equivalents
-$34M
← FY 2019
All Quarters
Q2 2019 →
